GPFA
ADMA icon

Game Plan Financial Advisors’s ADMA Biologics ADMA Stock Holding History

Game Plan Financial Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,000
Closed -$6.6K – 385
2024
Q1 		$6.6K Hold
1,000
– – ﹤0.01% 291
2023
Q4 		$4.52K Buy
+1,000
New +$3.7K ﹤0.01% 299
2022
Q4 		– Sell
-41,000
Closed -$100K – 88
2022
Q3 		$100K Buy
+41,000
New +$98.4K 0.08% 74

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Game Plan Financial Advisors's ADMA Position: Q2 2024 in Review

Game Plan Financial Advisors sold out of ADMA Biologics (ADMA) in Q2 2024, closing a stake of 1,000 shares — an estimated $6.6K sold.

Game Plan Financial Advisors first reported a position in ADMA in Q3 2022 and held it in 3 quarters. The position peaked at $100K in Q3 2022. 252 funds tracked by Wall St. Rank hold ADMA as of Q2 2024.

  • Game Plan Financial Advisors reported no remaining ADMA Biologics position as of Q2 2024 after selling out during the quarter.
  • Game Plan Financial Advisors sold 1,000 ADMA Biologics shares in Q2 2024, an estimated $6.6K.
  • Game Plan Financial Advisors first reported a position in ADMA Biologics in Q3 2022 and held it in 3 quarters.
  • Game Plan Financial Advisors's ADMA Biologics position peaked at $100K in Q3 2022.
  • 252 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2024.

Based on Game Plan Financial Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.